$7.26
▼ -13.6% Today
as of Jul 23, 14:19 ET
Last 30 days
Recent Press Releases & News
Genprex’s Reqorsa combo secures Canadian patent for lung cancer
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
Genprex to Participate at BIO International Convention 2026
Overview
52-week range
$0.63
$55
12% of range
Avg surprise (last 1)
+68.3%
Avg reaction (last 2)
-0.3%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-0.64 | — | — | -146.2% | +2.5% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.17 | — | — | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.26 | $-0.82 | +68.3% | — | -3.2% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | — | -$99.99 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-3M | $-5M | $-4M | — | $-4M | $-7M |
| Net income | $-4M | — | $-4M | $-5M | $-4M | — | $-4M | $-6M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $18M | $8M | $1M | $1M | $3M | $2M | $1M | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $19M | $8M | $2M | $2M | $4M | $2M | $2M | $4M |
| Total assets | $20M | $10M | $4M | $4M | $6M | $4M | $4M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $3M | $2M | $3M | — | — | $3M | — | — |
| Total equity | $17M | $8M | $767,807 | $1M | $4M | $2M | $2M | $4M |
Implied volatility — last 90 days
No IV snapshots yet for GNPX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.